Trial Profile
A Randomized, Controlled Study to Evaluate Safety and Efficacy of Fibrin Sealant VH S/D 4 S-APR (Artiss) for Tissue Adherence and Hemostasis and To Improve Wound Healing in Subjects Undergoing Endoscopic Browlift
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2017
Price :
$35
*
At a glance
- Drugs Fibrin (Primary)
- Indications Ecchymosis; Oedema
- Focus Therapeutic Use
- 01 Mar 2017 New trial record